Over the last six years, three GLP-1 drugs have been approved for children aged 10 and older with Type 2 diabetes. Now this rapidly growing patient population is a step closer to gaining access to Eli ...
The number of teens and young adults taking GLP-1 drugs has increased by 594 percent—but scientists are still trying to understand the long-term effects. The success of GLP-1 agonist weight-loss drugs ...
Gujarat CM Bhupendra Patel launched a statewide programme for Type-1 Diabetes to provide holistic treatment to all affected children. The initiative will make care available in remote areas and ...